Press Release NRG Therapeutics Presents Data on Lead Clinical Asset NRG5051 Confirming Novel Disease-Modifying Approach to ALS 3 hours ago
Press Release NRG Therapeutics Announces the Appointment of Claus Sundgreen M.D. as Chief Medical Officer Aug 3